Skip to main content
. 2021 Apr 12;73(8):1355–1361. doi: 10.1093/cid/ciab301

Table 1.

Study Population Characteristics

Enrollment Trimester (%) Gestational Age at Delivery (weeks)b Mean (range) At least 2 Doses IPTp-SP n (%) ITN % Malaria Treatmentc Mean (range)
Group PM statusa n (%) Gestational Age at Enrollment (weeks) Mean (range) 1st 2nd 3rd
Primigravid PM− 116 20.6 (7.1–36.0) 20.7 57.8 21.5 38.9 (32.0–41.6) 83 (72.2) 50.0
PM+ 318 (73.3%) 20.8 (5.1–36.1) 13.5 72.0 14.5 38.7 (29.6–42.0) 214 (67.1) 39.6 1.3 (0–5)
Secundigravid PM− 118 20.5 (5.1–36.0) 21.2 59.3 19.5 39.0 (31.6–42.3) 91 (77.7) 53.4
PM+ 241 (67.1%) 20.6 (6.3–36.0) 12.9 72.2 14.9 39.1 (32.1–42.7) 175 (72.3) 52.3 1.2 (0–4)
Multigravid PM− 373 20.6 (5.0–36.0) 16.6 66.8 16.6 39.6 (32.4–43.0) 279 (75.0) 52.5
PM+ 684 (64.7%) 20.5 (5.6–39.0) 15.8 69.2 15.1 39.5 (30.3–42.7) 498 (72.7) 55.7 1.1 (0–3)

Abbreviations: IPTp-SP, intermittent preventative treatment in pregnancy with sulfadoxine-pyrimethamine; ITN, insecticide treated net; PM, malaria in pregnancy.

a PM−: no infections; PM+ at least 1 infection detected by blood smear microscopy or polymerase chain reaction (PCR).

b Gestational age at delivery includes viable singleton births.

cMean and range of treatment rounds with antimalarial drugs.